Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Nov 12;10:548300. doi: 10.3389/fonc.2020.548300

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2020 Hu, An, Sun, Wang, Du, Li, Chi and Liu

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Metabolic phenotype variations induced by anlotinib treatment. (A) Overview of pathway analysis of the significantly changed metabolites between SH1 and C1D14. (B) Overview of pathway analysis of the significantly changed metabolites between SH1 and C2D14. All dots represented matched pathways from topology pathway analysis. Pathways were colored according to their significance values from pathway enrichment analysis, with gradations from yellow, having the least significance, to red having the highest significance. (C) A Venn diagram showing the shared metabolite numbers between SH1-C1D14 and SH1-C2D14. (D) Concentration trends of six metabolites on the time points of SH1, C1D14, and C2D14.